arrow
M

Mark Pinese

The Kinghorn Cancer Centre
H指数:47
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline analysis of an international cohort of pediatric diffuse midline glioma patients

对国际队列儿童弥漫性中线胶质瘤患者的生殖系分析

2025-03-120
PRE
Congenital Titinopathy: Comprehensive Characterization of the Most Severe End of the Disease Spectrum
2025-01-240
OAAI
PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES

弥漫性中线胶质瘤的儿科患者在同源重组基因中表现出意想不到的种系变异患病率

2024-06-180
OAAI
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial
CANCER
IF5.1
2023-06-297
OAAI
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
2023-06-237
OA
Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications

Introme准确预测编码和非编码变异对基因剪接的影响,具有临床应用

2023-05-178
OAAI
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

肿瘤细胞的体外和体内药物筛选确定高危儿童癌症的新疗法

2021-12-2019
OAAI
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

全基因组,转录组和甲基化分析可增强高风险儿科癌症的可操作靶标发现

2020-10-05229
PREAI
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly
2020-01-2352
OAAI
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

由胰腺癌细胞p53-status驱动的CAF层次结构通过perlecan创造了一个促转移和化学抗性的环境

2019-08-12184
OAAI
Precision Oncology in Surgery Patient Selection for Operable Pancreatic Cancer
2018-12-1849
OAAI
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
2018-10-0916
OAAI
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
2018-09-1794
OAAI